CORRELATION OF INFLAMMATION PARAMETERS WITH PERIPHERAL NEUROPATHIC PAIN IN BREAST CANCER PATIENTS UNDERWENT THROUGH PACLITAXEL CHEMOTHERAPY

This study was aimed to correlatethe inflammation parameters with peripheral neuropathic pain in patientsunderwent paclitaxel chemotherapy after diagnosed with breast cancer. Histopathologically, patients who were diagnosed with breast cancer and received adjuvant paclitaxel treatment in the medical...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Fresenius environmental bulletin 2021-07, Vol.30 (7A), p.9547
Hauptverfasser: Gundogdu, Utku Donem, Cenikli, Utku, Coban, Funda Karabag, Tanriverdi, Ozgur
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 7A
container_start_page 9547
container_title Fresenius environmental bulletin
container_volume 30
creator Gundogdu, Utku Donem
Cenikli, Utku
Coban, Funda Karabag
Tanriverdi, Ozgur
description This study was aimed to correlatethe inflammation parameters with peripheral neuropathic pain in patientsunderwent paclitaxel chemotherapy after diagnosed with breast cancer. Histopathologically, patients who were diagnosed with breast cancer and received adjuvant paclitaxel treatment in the medical oncology clinic fromMarch 2019 to January were included in the study. These patients had operated breast cancer and received weekly adjuvant paclitaxel treatment neuropathic pain questionnaire. A total of 64 patients were included in this study where 42 (65.6%) of them had no neuropathy while 22 (34.4) had neuropathy. The general average age was 50.42 (SD: 10) where the oldest person was 73 years old while the youngest one was 29.No significant difference was found between the mean age of the patients with neuropathy and the mean age of the patients without it. There was also no statistical significancedifference in I, II measurements of NLR and TLR variables between the groups with and without neutropathy. No relationship was found between docetaxel-induced neuropathy and neutrophil/lymphocyte parameters in patients with neuropathic pain.
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2557866945</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2557866945</sourcerecordid><originalsourceid>FETCH-LOGICAL-p113t-3e24ef5dcdfc962c9dfd910df52de6a44f35e50eaae4fc97fcf66cccc03ba1493</originalsourceid><addsrcrecordid>eNotjc1qwzAQhE1poSHNOwh6Nug_8VFVlVggS0aRSXsKri0dQmnSOHmKvnRV0rnszDL77V0xQxzBEhNI77OHaFVSjqrHYjFNB5jF8RJzMit-pPNeGRG0s8CtgbZrI5rmllvhRaOC8luw06EGrfK6rZUXBljVedeKUGuZa9rmQ_DildgGIIWVyudt0MqGLejsq_K7bEGoves2mSOk0UG8KQNkrRoX_pjt-1PxkPrPKS7-57zo1irIujRuo6Uw5QkhcilJxDQmNg5jGiqOh2pMY4XgmBgeI-8pTYRFBmPfR5obyzQkzocsSD56RCsyL55v3NP5-H2N02V_OF7PX_nlHjO2XHFeUUZ-Ad4_V2c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2557866945</pqid></control><display><type>article</type><title>CORRELATION OF INFLAMMATION PARAMETERS WITH PERIPHERAL NEUROPATHIC PAIN IN BREAST CANCER PATIENTS UNDERWENT THROUGH PACLITAXEL CHEMOTHERAPY</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Gundogdu, Utku Donem ; Cenikli, Utku ; Coban, Funda Karabag ; Tanriverdi, Ozgur</creator><creatorcontrib>Gundogdu, Utku Donem ; Cenikli, Utku ; Coban, Funda Karabag ; Tanriverdi, Ozgur</creatorcontrib><description>This study was aimed to correlatethe inflammation parameters with peripheral neuropathic pain in patientsunderwent paclitaxel chemotherapy after diagnosed with breast cancer. Histopathologically, patients who were diagnosed with breast cancer and received adjuvant paclitaxel treatment in the medical oncology clinic fromMarch 2019 to January were included in the study. These patients had operated breast cancer and received weekly adjuvant paclitaxel treatment neuropathic pain questionnaire. A total of 64 patients were included in this study where 42 (65.6%) of them had no neuropathy while 22 (34.4) had neuropathy. The general average age was 50.42 (SD: 10) where the oldest person was 73 years old while the youngest one was 29.No significant difference was found between the mean age of the patients with neuropathy and the mean age of the patients without it. There was also no statistical significancedifference in I, II measurements of NLR and TLR variables between the groups with and without neutropathy. No relationship was found between docetaxel-induced neuropathy and neutrophil/lymphocyte parameters in patients with neuropathic pain.</description><identifier>ISSN: 1018-4619</identifier><identifier>EISSN: 1610-2304</identifier><language>eng</language><publisher>Freising: Parlar Scientific Publications</publisher><subject>Age ; Breast cancer ; Chemotherapy ; Inflammation ; Leukocytes (neutrophilic) ; Lymphocytes ; Mean ; Paclitaxel ; Pain ; Parameters ; Patients ; Peripheral neuropathy</subject><ispartof>Fresenius environmental bulletin, 2021-07, Vol.30 (7A), p.9547</ispartof><rights>Copyright Parlar Scientific Publications Jul 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Gundogdu, Utku Donem</creatorcontrib><creatorcontrib>Cenikli, Utku</creatorcontrib><creatorcontrib>Coban, Funda Karabag</creatorcontrib><creatorcontrib>Tanriverdi, Ozgur</creatorcontrib><title>CORRELATION OF INFLAMMATION PARAMETERS WITH PERIPHERAL NEUROPATHIC PAIN IN BREAST CANCER PATIENTS UNDERWENT THROUGH PACLITAXEL CHEMOTHERAPY</title><title>Fresenius environmental bulletin</title><description>This study was aimed to correlatethe inflammation parameters with peripheral neuropathic pain in patientsunderwent paclitaxel chemotherapy after diagnosed with breast cancer. Histopathologically, patients who were diagnosed with breast cancer and received adjuvant paclitaxel treatment in the medical oncology clinic fromMarch 2019 to January were included in the study. These patients had operated breast cancer and received weekly adjuvant paclitaxel treatment neuropathic pain questionnaire. A total of 64 patients were included in this study where 42 (65.6%) of them had no neuropathy while 22 (34.4) had neuropathy. The general average age was 50.42 (SD: 10) where the oldest person was 73 years old while the youngest one was 29.No significant difference was found between the mean age of the patients with neuropathy and the mean age of the patients without it. There was also no statistical significancedifference in I, II measurements of NLR and TLR variables between the groups with and without neutropathy. No relationship was found between docetaxel-induced neuropathy and neutrophil/lymphocyte parameters in patients with neuropathic pain.</description><subject>Age</subject><subject>Breast cancer</subject><subject>Chemotherapy</subject><subject>Inflammation</subject><subject>Leukocytes (neutrophilic)</subject><subject>Lymphocytes</subject><subject>Mean</subject><subject>Paclitaxel</subject><subject>Pain</subject><subject>Parameters</subject><subject>Patients</subject><subject>Peripheral neuropathy</subject><issn>1018-4619</issn><issn>1610-2304</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNotjc1qwzAQhE1poSHNOwh6Nug_8VFVlVggS0aRSXsKri0dQmnSOHmKvnRV0rnszDL77V0xQxzBEhNI77OHaFVSjqrHYjFNB5jF8RJzMit-pPNeGRG0s8CtgbZrI5rmllvhRaOC8luw06EGrfK6rZUXBljVedeKUGuZa9rmQ_DildgGIIWVyudt0MqGLejsq_K7bEGoves2mSOk0UG8KQNkrRoX_pjt-1PxkPrPKS7-57zo1irIujRuo6Uw5QkhcilJxDQmNg5jGiqOh2pMY4XgmBgeI-8pTYRFBmPfR5obyzQkzocsSD56RCsyL55v3NP5-H2N02V_OF7PX_nlHjO2XHFeUUZ-Ad4_V2c</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Gundogdu, Utku Donem</creator><creator>Cenikli, Utku</creator><creator>Coban, Funda Karabag</creator><creator>Tanriverdi, Ozgur</creator><general>Parlar Scientific Publications</general><scope>7ST</scope><scope>7T7</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>SOI</scope></search><sort><creationdate>20210701</creationdate><title>CORRELATION OF INFLAMMATION PARAMETERS WITH PERIPHERAL NEUROPATHIC PAIN IN BREAST CANCER PATIENTS UNDERWENT THROUGH PACLITAXEL CHEMOTHERAPY</title><author>Gundogdu, Utku Donem ; Cenikli, Utku ; Coban, Funda Karabag ; Tanriverdi, Ozgur</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p113t-3e24ef5dcdfc962c9dfd910df52de6a44f35e50eaae4fc97fcf66cccc03ba1493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Age</topic><topic>Breast cancer</topic><topic>Chemotherapy</topic><topic>Inflammation</topic><topic>Leukocytes (neutrophilic)</topic><topic>Lymphocytes</topic><topic>Mean</topic><topic>Paclitaxel</topic><topic>Pain</topic><topic>Parameters</topic><topic>Patients</topic><topic>Peripheral neuropathy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gundogdu, Utku Donem</creatorcontrib><creatorcontrib>Cenikli, Utku</creatorcontrib><creatorcontrib>Coban, Funda Karabag</creatorcontrib><creatorcontrib>Tanriverdi, Ozgur</creatorcontrib><collection>Environment Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environment Abstracts</collection><jtitle>Fresenius environmental bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gundogdu, Utku Donem</au><au>Cenikli, Utku</au><au>Coban, Funda Karabag</au><au>Tanriverdi, Ozgur</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CORRELATION OF INFLAMMATION PARAMETERS WITH PERIPHERAL NEUROPATHIC PAIN IN BREAST CANCER PATIENTS UNDERWENT THROUGH PACLITAXEL CHEMOTHERAPY</atitle><jtitle>Fresenius environmental bulletin</jtitle><date>2021-07-01</date><risdate>2021</risdate><volume>30</volume><issue>7A</issue><spage>9547</spage><pages>9547-</pages><issn>1018-4619</issn><eissn>1610-2304</eissn><abstract>This study was aimed to correlatethe inflammation parameters with peripheral neuropathic pain in patientsunderwent paclitaxel chemotherapy after diagnosed with breast cancer. Histopathologically, patients who were diagnosed with breast cancer and received adjuvant paclitaxel treatment in the medical oncology clinic fromMarch 2019 to January were included in the study. These patients had operated breast cancer and received weekly adjuvant paclitaxel treatment neuropathic pain questionnaire. A total of 64 patients were included in this study where 42 (65.6%) of them had no neuropathy while 22 (34.4) had neuropathy. The general average age was 50.42 (SD: 10) where the oldest person was 73 years old while the youngest one was 29.No significant difference was found between the mean age of the patients with neuropathy and the mean age of the patients without it. There was also no statistical significancedifference in I, II measurements of NLR and TLR variables between the groups with and without neutropathy. No relationship was found between docetaxel-induced neuropathy and neutrophil/lymphocyte parameters in patients with neuropathic pain.</abstract><cop>Freising</cop><pub>Parlar Scientific Publications</pub></addata></record>
fulltext fulltext
identifier ISSN: 1018-4619
ispartof Fresenius environmental bulletin, 2021-07, Vol.30 (7A), p.9547
issn 1018-4619
1610-2304
language eng
recordid cdi_proquest_journals_2557866945
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Age
Breast cancer
Chemotherapy
Inflammation
Leukocytes (neutrophilic)
Lymphocytes
Mean
Paclitaxel
Pain
Parameters
Patients
Peripheral neuropathy
title CORRELATION OF INFLAMMATION PARAMETERS WITH PERIPHERAL NEUROPATHIC PAIN IN BREAST CANCER PATIENTS UNDERWENT THROUGH PACLITAXEL CHEMOTHERAPY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T06%3A39%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CORRELATION%20OF%20INFLAMMATION%20PARAMETERS%20WITH%20PERIPHERAL%20NEUROPATHIC%20PAIN%20IN%20BREAST%20CANCER%20PATIENTS%20UNDERWENT%20THROUGH%20PACLITAXEL%20CHEMOTHERAPY&rft.jtitle=Fresenius%20environmental%20bulletin&rft.au=Gundogdu,%20Utku%20Donem&rft.date=2021-07-01&rft.volume=30&rft.issue=7A&rft.spage=9547&rft.pages=9547-&rft.issn=1018-4619&rft.eissn=1610-2304&rft_id=info:doi/&rft_dat=%3Cproquest%3E2557866945%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2557866945&rft_id=info:pmid/&rfr_iscdi=true